Lab Information

W. Alton Russell (PhD)

Associate Investigator
Centre for Outcomes Research and Evaluation
Department of Epidemiology, Biostatistics and Occupational Health (McGill)

Research Profile

 Fundamental: 0%
 Clinical: 0%
 Epidemiology: 0%
 Evaluation: 0%
 This email address is being protected from spambots. You need JavaScript enabled to view it.
 http://mchi.mcgill.ca/decision-modeling-lab/

Keywords

Decision analysis • cost-effectiveness • simulation modeling • blood donation and transfusion • transfusion-transmitted infections

Research Interests

My research program aims to enable the efficient and effective use of finite healthcare resources by developing data-driven analyses that inform health policy and clinical decisions. I use methods from decision analysis, simulation, health economics, operations research, epidemiology, and data science. I have developed decision analytic models and data-driven analyses for multiple areas of health policy and clinical practice, including blood donation and transfusion, managing pediatric kidney disease, opioid use disorder and overdose, and gastroenterology.


Team Members

Name Position

Latest Publications

  1. Li, N., Pham, T., Cheng, C., McElfresh, D. C., Metcalf, R. A., Russell, W. A., Birch, R., Yurkovich, J. T., Montemayor-Garcia, C., Lane, W. J., Tobian, A. A. R., Roubinian, N., Seheult, J. & Goel, R. (2023). Blood Demand Forecasting and Supply Management: An Analytical Assessment of Key Studies Utilizing Novel Computational Techniques. Transfusion medicine reviews, p. 150768.
  2. Vivas-Valencia, C., Dong, H., Stringfellow, E. J., Russell, W. A., Morgan, J. R., Tadrous, M. & Jalali, M. S. (2023). Factors Associated With Abrupt Discontinuation of Long-Term High-Dose Opioid Treatment. JAMA network open, vol. 6, p. e2341416.
  3. Claypool, A. L., DiGennaro, C., Russell, W. A., Yildirim, M. F., Zhang, A. F., Reid, Z., Stringfellow, E. J., Bearnot, B., Schackman, B. R., Humphreys, K. & Jalali, M. S. (2023). Cost-effectiveness of Increasing Buprenorphine Treatment Initiation, Duration, and Capacity Among Individuals Who Use Opioids. JAMA health forum, vol. 4, p. e231080.
  4. Dong, H., Stringfellow, E. J., Russell, W. A. & Jalali, M. S. (2023). Racial and Ethnic Disparities in Buprenorphine Treatment Duration in the US. JAMA psychiatry, vol. 80, p. 93-95.
  5. Russell, W. A., Scheinker, D. & Custer, B. (2022). Individualized risk trajectories for iron-related adverse outcomes in repeat blood donors. Transfusion, vol. 62, p. 116-124.
  6. Russell, W. A., Owusu-Ofori, S., Owusu-Ofori, A., Micah, E., Norman, B. & Custer, B. (2021). Cost-effectiveness and budget impact of whole blood pathogen reduction in Ghana. Transfusion, vol. 61, p. 3402-3412.
  7. Russell, W. A., Custer, B. & Brandeau, M. L. (2021). Optimal portfolios of blood safety interventions: test, defer or modify?. Health care management science, vol. 24, p. 551-568.
  8. Russell, W. A., Grebe, E. & Custer, B. (2021). Factors driving availability of COVID-19 convalescent plasma: Insights from a demand, production, and supply model. Transfusion, vol. 61, p. 1370-1376.
  9. Russell, W. A. (2021). Estimating the Effect of Discontinuing Universal Screening of Donated Blood for Zika Virus in the 50 U.S. States. Annals of internal medicine, vol. 174, p. 728-730.
  10. Campbell, J. R., Uppal, A., Oxlade, O., Fregonese, F., Bastos, M. L., Lan, Z., Law, S., Oh, C. E., Russell, W. A., Sulis, G., Winters, N., Yanes-Lane, M., Brisson, M., Laszlo, S., Evans, T. G. & Menzies, D. (2020). [Not Available]. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, vol. 192, p. E1734-E1746.
More on PubMed